Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana

Background: Cryptococcal antigen (CrAg) screening in individuals with advanced HIV reduces cryptococcal meningitis (CM) cases and deaths. The World Health Organization recently recommended increasing screening thresholds from CD4 ≤100 cells/µL to ≤200 cells/µL. CrAg screening at CD4 ≤100 cells/µL is...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenforde, Mark W., Muthoga, Charles, Ponatshego, Ponego, Ngidi, Julia, Mine, Madisa, Greene, Greg, Jordan, Alexander, Chiller, Tom, Larson, Bruce A., Jarvis, Joseph N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767426/
https://www.ncbi.nlm.nih.gov/pubmed/35087954
http://dx.doi.org/10.12688/wellcomeopenres.16624.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767426/
https://www.ncbi.nlm.nih.gov/pubmed/35087954
http://dx.doi.org/10.12688/wellcomeopenres.16624.2

Ejemplares similares